Reading this on a mobile device? Try our optimized mobile version here:

March 25, 2013
Sign upForwardArchiveAdvertise

  Top Stories 
  • FDA OKs additional indication for SPECT agent AdreView
    The FDA has allowed the use of GE Healthcare's SPECT imaging agent AdreView, also known as iobenguane I-123, in the evaluation of myocardial sympathetic innervation in patients with New York Heart Association class II or III heart failure and left-ventricular ejection fraction at or lower than 35%. The company said the agent has the potential to detect the likelihood that patients' heart failure will advance. (free registration) (3/22) LinkedInFacebookTwitterEmail this Story
  Medical Focus 
  • High-dose statins may raise kidney damage risk, study finds
    People who took high doses of cholesterol-lowering statin drugs had a 34% greater risk of being hospitalized for acute kidney injury within the first 120 days of treatment than those who took lower doses, a large study in Canada found. "The lowest dose of statin required to achieve therapeutic goals should be prescribed," study author Colin Dormuth said. The findings were published online in the journal BMJ. HealthDay News (3/20) LinkedInFacebookTwitterEmail this Story
  • Other News
  Regulatory & Policy 
  • CMS announces MU targets for hospitals, physician practices for 2013
    CMS said at the HIMSS13 conference that it anticipates 80% of qualified hospitals and 50% of qualified physician practices will become meaningful users this year. Acting CMS Administrator Marilyn Tavenner said 2013 would be "busy," with a focus on education. "We're going to spend a lot more time with physicians -- helping physicians learn, and helping physicians work with their current vendors to make things a little easier for them," Tavenner said. Family Practice News (3/19) LinkedInFacebookTwitterEmail this Story
  ASNC News 
  • Technologists -- NMTCB Call for Directors
    The Nuclear Medicine Technology Certification Board (NMTCB) is seeking applicants to serve on the Board of Directors. This is an excellent opportunity to become involved in one of the more challenging and important areas of your profession -- establishing standards of professional competency. The four-year term for a newly elected director begins on Jan. 1, 2014. Applications are available. LinkedInFacebookTwitterEmail this Story
  • Physicians -- Registration is Now Open for Board Prep!
    ASNC is pleased to announce that registration is open for both Nuclear Cardiology Board Exam Preparation Courses in 2013. The first program will be July 26-28 in Boston; the second is an Ancillary program for ASNC2013 and will be held in Chicago, Sept. 25-26. Go to to learn more. Register today! LinkedInFacebookTwitterEmail this Story
Learn more about ASNC ->ASNC Home | Join ASNC | Education and Meetings
Annual Meeting | Journal of Nuclear Cardiology

I love those who can smile in trouble, who can gather strength from distress, and grow brave by reflection. 'Tis the business of little minds to shrink."
--Leonardo da Vinci,
Italian artist, scientist and writer

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
A powerful website for SmartBrief readers including:
 Recent ASNC SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information